US2002098580A1PendingUtilityA1
MDM interacting protein and methods of use thereof
Est. expiryFeb 23, 2019(expired)· nominal 20-yr term from priority
A61P 35/00C07K 14/47A61P 43/00C07K 2319/00
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are complexes of the MDM2 protein and a novel MDM2-interacting protein (MDMIP). Also disclosed are nucleic acids encoding the MDMIP polypeptide, as well as derivatives, fragments, analogs and homologs of the MDMIP polypeptide and MDM2-MDMIP complexes.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A purified complex comprising an MDMIP binding domain of an MDM2polypeptide and an MDM2 binding domain of an MDMIP polypeptide.
2 . The complex of claim 1 , wherein the MDMIP binding domain of the MDM2 polypeptide is present in a polypeptide comprising the amino acid sequence of an MDMIP polypeptide.
3 . The complex of claim 1 , wherein the MDM2 binding domain of the MDMIP polypeptide is present in a polypeptide comprising the amino acid sequence of an MDMIP polypeptide.
4 . The complex of claim 3 , wherein the MDMIP binding domain of the MDM2 polypeptide is present in a polypeptide comprising the amino acid sequence of an MDMIP polypeptide.
5 . The complex of claim 1 , wherein the MDM2 polypeptide is a human MDM2 polypeptide.
6 . The complex of claim 5 , wherein the MDMIP polypeptide is a human MDMIP polypeptide.
7 . The complex of claim 1 , wherein the MDMIP polypeptide is a human MDMIP polypeptide.
8 . The complex of claim 1 , wherein the MDMIP binding domain comprises a sequence that is at least 90% identical to the amino acid sequence of a region of an MDMIP polypeptide comprising the amino acid sequence of SEQ ID NO: 2 .
9 . The complex of claim 1 , wherein the MDMIP polypeptide comprises a sequence that is at least 95% identical to the amino acid sequence of a human MDMIP polypeptide including the amino acid sequence of SEQ ID NO: 2 .
10 . The complex of claim 1 , wherein the MDMIP polypeptide comprises the amino acid sequence of SEQ ID NO: 2 .
11 . The complex of claim 10 , wherein the MDM2 polypeptide comprises the amino acid sequence of SEQ ID NO: 4 .
12 . The complex of claim 1 , wherein the MDM2 polypeptide comprises the amino acid sequence of SEQ ID NO: 4 .
13 . The complex of claim 1 , wherein the polypeptide comprising the MDMIP binding domain is labeled.
14 . The complex of claim 1 , wherein the polypeptide comprising the MDM2 domain is labeled.
15 . The complex of claim 1 , wherein the MDM2-binding domain of the MDMIP polypeptide is a fragment of an MDMIP polypeptide.
16 . The complex of claim 1 , wherein the MDMIP binding domain of the MDM2 polypeptide is a fragment of an MDM2 polypeptide.
17 . A chimeric polypeptide comprising six or more amino acids of an MDM2 polypeptide covalently linked to six or more amino acids of an MDMIP polypeptide.
18 . The chimeric polypeptide of claim 17 , wherein the amino acids of the MDM2 polypeptide comprise an MDMIP-binding domain.
19 . The chimeric polypeptide of claim 17 , wherein the amino acids of the MDMIP polypeptide comprise an MDM2-binding domain.
20 . The chimeric polypeptide of claim 17 , wherein the MDM2 binding domain comprises an amino acid sequence at lest 90% identical to the amino acid sequence of SEQ ID NO: 2 .
21 . A pharmaceutical composition comprising the complex of claim 1.Join the waitlist — get patent alerts
Track US2002098580A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.